Breast Cancer Research Team Reports Infection Trend in Ongoing Clinical Trial That Has Implication on Current Treatments City of Hope is currently conducting an ongoing clinical trial exploring the trend...

Roughly 15-20% of people diagnosed with colorectal cancer (CRC), the third most common cancer diagnosed in both sexes in the U.S., excluding skin cancer, will have tumors with deficient mismatch...

ImugeneLeslie Chong  Managing Director and Chief Executive Officer +61 458 040 433   City of HopeCONTACTLetisia Marquez626-476-7593lemarquez@coh.org Imugene enhances portfolio with novel CD19-expressing...

Laleh Melstrom, M.D., M.S.Remote Perioperative Telemonitoring of Patient-generated Physiologic Health Data and Patient-reported Outcomes Patient-generated health data (PGHD) and patient-reported outcomes (PROs) are increasingly being used in...

From April 10 to 15, the brightest minds in the field of oncology and medicine will gather for the first week of this year’s all-virtual AACR Annual Meeting. The...

Overcoming CAR T cell therapy limitations to treat solid tumor cancersBy genetically engineering a tumor-selective oncolytic virus to deliver the surface antigen CD19 for expression on solid tumor...

Prostate cancer cells Internationally recognized prostate cancer researcher and associate professor of medicine in the Department of Medical Oncology & Therapeutics Research, Tanya Dorff, M.D., has focused heavily on...

Kommah McDowell was just 29 when she found a painful mass in her right breast. For seven months in 2005, her primary care physician repeatedly reassured her that she was too...

The current pandemic is driven by a respiratory infection, the novel coronavirus that causes COVID-19. Quite naturally, patients with lung cancer may be particularly worried. The question comes to mind: Does...

Brushfires and wildfires affect a variety of states during fire season, making it especially important for patients with cancer and compromised immune systems to protect themselves from the harm and...